Worldwide: Life Sciences, Biotechnology & Nanotechnology

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

Brazilian Government Launches The National Bioeconomy Development Plan (PNDBio)

The Federal Government has launched the National Bioeconomy Development Plan (PNDBio), established under the National Bioeconomy Strategy created by Decree No. 12,044/2024.

Brazil Environment

MB

Mayer Brown

Atualizações regulatórias: alimentos, medicamentos, cosméticos e governança sanitária

New regulations and technical adjustments expand compliance requirements, tighten safety criteria, and seek greater efficiency in regulatory processes and market access across Brazil's life sciences sector. This newsletter compiles the most critical regulatory updates affecting pharmaceuticals, supplementary health, food products, and other regulated sectors under ANVISA and professional councils.

Brazil Healthcare

KL

KLA Advogados

Patent Law Reform In Mexico: A Strategic Turning Point, Particularly For The Pharma Sector

In April 2026, Mexico implemented a significant reform of its intellectual property legislation, with the objective to modernise the system, accelerate procedures and provide greater legal certainty to innovators.

NG

Novagraaf Group

Regulatory Standards Impact The Healthcare Sector, Agribusiness, And Other Regulated Products

Check recent decisions by regulatory agencies such as Anvisa and ANTT, as well as bills passed by Congress, that affect strategies and operations in regulated sectors...

Brazil Healthcare

KL

KLA Advogados

Normas regulatórias afetam setores de saúde, agronegócio e outros produtos regulados

Brazil Healthcare

KL

KLA Advogados

Brasília em Pauta - Edição Nº 231

Brazil Litigation

MB

Mayer Brown

CFM Regulates The Use Of AI In Medicine In A New Resolution

Brazil Healthcare

KL

KLA Advogados

Brasília em Pauta - Edição Nº 230

MB

Mayer Brown

Atualizações regulatórias: saúde, agronegócio, cosméticos e mais

Brazil Healthcare

KL

KLA Advogados

ANVISA, MAPA e cannabis: atualizações recentes em Life Sciences

Brazil Cannabis

KL

KLA Advogados

Radar regulatório ANVISA 2026: 15 temas-chave da Agenda Regulatória

Brazil Healthcare

KL

KLA Advogados

Hot Topics Regulatórios Em Life Sciences Para 2026

Brazil Healthcare

KL

KLA Advogados

Publicación de acciones de simplificación para trámites ante la COFEPRIS

Mexico Healthcare

GT

Greenberg Traurig, LLP

Publicación de acciones de simplificación y listados de dispositivos médicos para efectos del registro sanitario

Mexico Healthcare

GT

Greenberg Traurig, LLP

New Mexican Customs Law – Nueva Ley Aduanera De Mexico

Mexico International

BG

Braumiller Law Group, PLLC

Preços de transferência em commodities é tema de mesa redonda no KLA (Video)

KL

KLA Advogados

OFAC Sanctions Cartel-Linked Timeshare Resort In Mexico: What Hospitality And Travel Companies Should Know

Mexico International

FL

Foley & Lardner

Continued Shakeup In Venezuela Sanctions: New OFAC Licenses And FAQs Expand Opportunities While Raising Compliance Stakes

Venezuela International

LB

Lewis Brisbois Bisgaard & Smith LLP

Cláusulas societárias, haveres e quotas: confira decisões recentes em Direito Societário

Brazil Commercial

KL

KLA Advogados

New Agreement To Accelerate Importation Of Health Products Through PAHO.

On June 11, 2025, was published in the DOF the "AGREEMENT recognizing as equivalent the requirements established in the Health Regulation and the technical evaluation procedures...

Mexico Healthcare

O

OLIVARES

Brasília Em Pauta – Edição Nº 205

O "Brasília em Pauta" é um boletim semanal preparado pela equipe de Contencioso de Brasília, contendo os principais casos a serem julgados...

Brazil Litigation

MB

Mayer Brown

Decree For The Promotion Of Pharmaceutical Investment And The So-Called "Plant Requirement"

On June 2, 2025, the "DECREE to promote investment within the national territory to strengthen the development of the pharmaceutical industry and the production of health products...

Mexico Healthcare

O

OLIVARES

Publicación De Acciones De Simplificación Para Trámites Ante La Comisión Federal Para La Protección De Riesgos Sanitarios

El pasado 27 de marzo de 2025, la Comisión Federal para la Protección contra Riesgos Sanitarios ("COFEPRIS") publicó en el Diario Oficial de la Federación (el "DOF") el Acuerdo por el que se establecen acciones de simplificación para trámites que se realizan ante la COFEPRIS.

Mexico Healthcare

GT

Greenberg Traurig, LLP

Brasília em Pauta – Edição Nº 201

Brazil Litigation

MB

Mayer Brown

Constitutional Reform Initiative Regarding Pharmaceutical Sovereignty And Safety

Mexico Healthcare

O

OLIVARES

New Mexico Becomes Third U.S. State To Prohibit PFAS In Products

Mexico Environment

BD

Beveridge & Diamond

Mexico Bans The Cultivation Of Genetically Modified Corn, Opening Door For Other Restrictions In The Future

Mexico Healthcare

BD

Beveridge & Diamond

Changes In Importation Of Health Products Coming From Abroad.

Mexico Healthcare

O

OLIVARES

Antitrust And Competition Life Sciences Quarterly Update Q2 2024

Brazil Healthcare

GP

Goodwin Procter LLP

An Introduction To Life Sciences

Mexico Healthcare

O

OLIVARES

Sócio de Direito Público aborda PPPs sociais em evento do GRI Club

Brazil Government

KL

KLA Advogados

Anvisa abre consulta pública para modelo de Sandbox Regulatório

Brazil Healthcare

KL

KLA Advogados

Anvisa Opens Public Consultation For Regulatory Sandbox Model

Brazil Healthcare

KL

KLA Advogados

An Introduction To Life Sciences

More than 20 years ago, as a result of innumerable and uncontainable violations of pharmaceutical patents, and in order to publicise the patents that protect allopathic medicines, several legislative amendments were made to the relevant legal bodies in Mexico.

Mexico Healthcare

O

OLIVARES

Sócio de Direito Público aborda PPPs sociais em evento do GRI Club

O sócio Roberto Lambauer atuará como co-chair no painel "PPPs Sociais: Eficiência como Pilar Central para o Sucesso de Projetos?"

Brazil Government

KL

KLA Advogados

Anvisa abre consulta pública para modelo de Sandbox Regulatório

Em 12 de agosto, a Agência Nacional de Vigilância Sanitária (ANVISA) iniciou a Tomada Pública de Subsídios – TPS nº 9, com o objetivo de coletar contribuições de interessados...

Brazil Healthcare

KL

KLA Advogados

Anvisa Opens Public Consultation For Regulatory Sandbox Model

Stakeholders can submit contributions until October 11 to help build an experimental regulatory environment aimed at fostering innovation and adapting sanitary regulations...

Brazil Healthcare

KL

KLA Advogados

Legal 500 Country Comparative Guides 2024

Mexico Healthcare

O

OLIVARES

Regulatory Certainty For Biosimilars On The Horizon

The frst time that biologics were ofcially recognised in the applicable legislation, the General Health Law, was in June 2009, with the inclusion of article 222-bis defning a ‘biologic/biotechnological product...

Mexico Healthcare

O

OLIVARES

Brasília Em Pauta – Edição Nº 162

O "Brasília em Pauta" é um boletim semanal preparado pela equipe de Contencioso de Brasília, contendo os principais casos a serem julgados pelo Supremo Tribunal Federal (STF)...

Brazil Environment

MB

Mayer Brown

Brasília em Pauta – Edição Nº 161

PAUTAS: STF – CONTROLE CONCENTRADO E REPERCUSSÃO GERAL | STJ – REPETITIVOS | TCU – PLENÁRIO | CÂMARA DOS DEPUTADOS | SENADO FEDERAL...

Brazil Strategy

MB

Mayer Brown

Uruguay Is On The Verge Of Joining The PCT

Have you ever looked at a world map and wondered how it is possible that there are still countries that are not part of the PCT?...

OB

Osha Bergman Watanabe & Burton LLP

Publicada nova Lei de Pesquisas Clínicas com seres humanos

Brazil Healthcare

KL

KLA Advogados

Brasília em Pauta – Edição Nº 153

Brazil Litigation

MB

Mayer Brown

Anvisa estabelece regras para registro otimizado de dispositivos médicos e dispositivos médicos para diagnóstico in vitro (IVD)

Brazil Healthcare

KL

KLA Advogados

Anvisa Establishes Rules For The Optimized Marketing Authorization Issuance Procedure Of Medical Devices And In Vitro Diagnostic (IVD)

Brazil Healthcare

KL

KLA Advogados

Anvisa regulamenta critérios para avaliações aprovadas por AREE

Brazil Healthcare

KL

KLA Advogados

The Patent Linkage System For Allopathic Medicines In Mexico

O

OLIVARES

Regulatory Certainty For Biosimilars In Mexico.

Mexico Healthcare

O

OLIVARES

Nobel Prize In Medicine 2023 – The Use Of Patents To Protect Basic And Applied Research

LA

Leão Advogados Associados

Lo Que Hay Que Saber Sobre El Resurgimiento Del Nearshoring En México

Mexico Commercial

TG

TMF Group BV

O Renascimento Do Nearshoring No México – O Que Você Precisa Saber

Mexico Commercial

TG

TMF Group BV

走近墨西哥近岸外包的复苏

Mexico Commercial

TG

TMF Group BV

Issues With The Patent Linkage System In Mexico

O

OLIVARES

Mexico's Nearshoring Resurgence – What You Need To Know

Mexico Commercial

TG

TMF Group BV

An Academic View Of Compulsory Licenses And Alternatives

O

OLIVARES

Newsletter – Setembro/22 | Direito Público

Brazil Healthcare

KL

KLA Advogados

See more

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More